JP2014520136A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520136A5 JP2014520136A5 JP2014516407A JP2014516407A JP2014520136A5 JP 2014520136 A5 JP2014520136 A5 JP 2014520136A5 JP 2014516407 A JP2014516407 A JP 2014516407A JP 2014516407 A JP2014516407 A JP 2014516407A JP 2014520136 A5 JP2014520136 A5 JP 2014520136A5
- Authority
- JP
- Japan
- Prior art keywords
- carrier
- coch
- acetyl
- immunostimulant
- allergic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000969 carrier Substances 0.000 claims 10
- 239000000203 mixture Substances 0.000 claims 8
- 230000003344 immunostimulant Effects 0.000 claims 7
- 239000003022 immunostimulating agent Substances 0.000 claims 7
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 230000003308 immunostimulating Effects 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 201000008937 atopic dermatitis Diseases 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 claims 3
- 208000006673 Asthma Diseases 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 2
- 206010020751 Hypersensitivity Diseases 0.000 claims 2
- 229960001438 IMMUNOSTIMULANTS Drugs 0.000 claims 2
- 230000002009 allergen Effects 0.000 claims 2
- 201000009910 diseases by infectious agent Diseases 0.000 claims 2
- 239000002778 food additive Substances 0.000 claims 2
- 235000013373 food additive Nutrition 0.000 claims 2
- 235000016709 nutrition Nutrition 0.000 claims 2
- 206010003645 Atopy Diseases 0.000 claims 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 claims 1
- 208000004262 Food Hypersensitivity Diseases 0.000 claims 1
- 231100000614 Poison Toxicity 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 206010046736 Urticarias Diseases 0.000 claims 1
- 230000000240 adjuvant Effects 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000172 allergic Effects 0.000 claims 1
- 201000009961 allergic asthma Diseases 0.000 claims 1
- 201000005794 allergic hypersensitivity disease Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 201000010435 allergic urticaria Diseases 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000038129 antigens Human genes 0.000 claims 1
- 108091007172 antigens Proteins 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003405 delayed action preparation Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 235000020932 food allergy Nutrition 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 238000009169 immunotherapy Methods 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 239000002574 poison Substances 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
- 229960005486 vaccines Drugs 0.000 claims 1
- 0 CCC(C(C1[C@@](O)OC(C(*)[C@](C)*CO*)[C@](O)OCCNC=C(COCC(COCc2c[n](CCO[C@]3OC(CO*)[C@@](C)C(*)C3O[C@@](C(*)C([C@@](*CO*)O*)O*)O)nn2)ClCc2c[n](CC*[C@@](*)C(C(*)[C@@](C)C3CO*)C3O[C@@](C([C@](C(O*)=*CO*)O*)O*)O)nn2)N=N)O*)[C@](*)C1O* Chemical compound CCC(C(C1[C@@](O)OC(C(*)[C@](C)*CO*)[C@](O)OCCNC=C(COCC(COCc2c[n](CCO[C@]3OC(CO*)[C@@](C)C(*)C3O[C@@](C(*)C([C@@](*CO*)O*)O*)O)nn2)ClCc2c[n](CC*[C@@](*)C(C(*)[C@@](C)C3CO*)C3O[C@@](C([C@](C(O*)=*CO*)O*)O*)O)nn2)N=N)O*)[C@](*)C1O* 0.000 description 1
Claims (15)
- 前記β−1,2−結合マンノオリゴ糖化合物の各Rがアセチル(COCH3)である、請求項1に記載の免疫賦活剤。
- 医薬品として使用するための、請求項1又は2に記載の免疫賦活剤。
- ワクチンのアジュバントとして使用するための、請求項1又は2に記載の免疫賦活剤。
- Treg及び/若しくはTh1型を誘導すること、並びに/又はTh2型免疫応答を阻害することによって予防又は処置できる状態の処置に使用するための、請求項1又は2に記載の免疫賦活剤、又はそれらの組合せ。
- 状態が、I型即時型アトピー性アレルギーである、請求項5に記載の使用のための免疫賦活剤。
- 状態が、
a)アトピー性湿疹/アトピー性皮膚炎症候群(AEDS)、
b)アレルギー性喘息、
c)アレルギー性鼻炎、
d)アレルギー性蕁麻疹、
e)食物アレルギー、
f)毒物アレルギー、及び
g)アレルギー性鼻結膜炎
からなる群から選択される、請求項5又は6に記載の使用のための免疫賦活剤。 - 状態が、感染性疾患である、請求項5に記載の免疫賦活剤。
- 前記β−1,2−結合マンノオリゴ糖化合物の各Rがアセチル(COCH 3 )である、請求項9に記載の免疫賦活組成物。
- 担体が、舌下及び/又はバッカル投与のための経粘膜担体である、請求項9又は10に記載の免疫賦活組成物。
- 特異的アレルゲン免疫療法のためのアレルゲン調製物;及び/又は追加的なアレルギー薬又は喘息薬をさらに含む、請求項9から11までのいずれか一項に記載の免疫賦活組成物。
- 感染性疾患に対するワクチン接種のための微生物特異的抗原;及び/又は抗微生物剤をさらに含む、請求項9から12までのいずれか一項に記載の免疫賦活組成物。
- 前記β−1,2−結合マンノオリゴ糖化合物の各Rがアセチル(COCH 3 )である、請求項14に記載の食品添加剤、又は栄養調製物。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161499229P | 2011-06-21 | 2011-06-21 | |
US61/499,229 | 2011-06-21 | ||
FI20115631 | 2011-06-21 | ||
FI20115631A FI20115631A0 (fi) | 2011-06-21 | 2011-06-21 | Immunostimulatoriset yhdisteet ja niiden käyttö |
PCT/FI2012/050650 WO2012175813A1 (en) | 2011-06-21 | 2012-06-21 | Multivalent [beta] - 1 - 2 - linked mannose oligosaccharides as immunostimulatory compounds and uses thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2014520136A JP2014520136A (ja) | 2014-08-21 |
JP2014520136A5 true JP2014520136A5 (ja) | 2015-07-30 |
JP6073306B2 JP6073306B2 (ja) | 2017-02-01 |
Family
ID=44206840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014516407A Expired - Fee Related JP6073306B2 (ja) | 2011-06-21 | 2012-06-21 | 免疫賦活化合物としての多価[β]−1,2−結合マンノースオリゴ糖及びその使用 |
Country Status (12)
Country | Link |
---|---|
US (1) | US9221861B2 (ja) |
EP (1) | EP2723754B1 (ja) |
JP (1) | JP6073306B2 (ja) |
KR (1) | KR20140108209A (ja) |
CN (1) | CN103814041B (ja) |
AU (1) | AU2012273838B2 (ja) |
CA (1) | CA2842136C (ja) |
DK (1) | DK2723754T3 (ja) |
ES (1) | ES2629052T3 (ja) |
FI (1) | FI20115631A0 (ja) |
PT (1) | PT2723754T (ja) |
WO (1) | WO2012175813A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3008978A1 (en) | 2015-12-22 | 2017-06-29 | Turun Yliopisto | Immunostimulatory adjuvants and uses thereof |
EP3672600A4 (en) * | 2017-08-21 | 2021-05-19 | Glycom A/S | SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS |
CN107712895A (zh) * | 2017-10-27 | 2018-02-23 | 成都长力元生物科技有限公司 | 一种预防和治疗花粉过敏症的保健食品及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6488929B2 (en) | 1994-05-23 | 2002-12-03 | Montana State University | Candida albicans phosphomannan complex as a vaccine |
AU8136801A (en) | 2000-07-31 | 2002-02-13 | Dermal Res Lab Inc | Methods of preventing or treating diseases and conditions using complex carbohydrates |
US7587171B2 (en) | 2005-03-09 | 2009-09-08 | Atc Technologies, Llc | Reducing interference in a wireless communications signal in the frequency domain |
CA2600696A1 (en) * | 2005-03-14 | 2006-09-21 | Governors Of The University Of Alberta | Synthetic anti-candida albicans oligosaccharide based vaccines |
WO2007010084A2 (en) * | 2005-07-15 | 2007-01-25 | Johannes Savolainen | Immunostimulatory oligo- and polysaccharides and uses thereof |
-
2011
- 2011-06-21 FI FI20115631A patent/FI20115631A0/fi not_active Application Discontinuation
-
2012
- 2012-06-21 KR KR1020147001662A patent/KR20140108209A/ko not_active Application Discontinuation
- 2012-06-21 ES ES12745500.4T patent/ES2629052T3/es active Active
- 2012-06-21 CA CA2842136A patent/CA2842136C/en not_active Expired - Fee Related
- 2012-06-21 DK DK12745500.4T patent/DK2723754T3/en active
- 2012-06-21 EP EP12745500.4A patent/EP2723754B1/en not_active Not-in-force
- 2012-06-21 JP JP2014516407A patent/JP6073306B2/ja not_active Expired - Fee Related
- 2012-06-21 PT PT127455004T patent/PT2723754T/pt unknown
- 2012-06-21 WO PCT/FI2012/050650 patent/WO2012175813A1/en active Application Filing
- 2012-06-21 CN CN201280040770.8A patent/CN103814041B/zh not_active Expired - Fee Related
- 2012-06-21 AU AU2012273838A patent/AU2012273838B2/en not_active Ceased
- 2012-06-21 US US14/128,464 patent/US9221861B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019500289A1 (en) | Vaccines directed against a human enteroviruses | |
JP2019048857A5 (ja) | ||
WO2017191258A9 (en) | Influenza mrna vaccines | |
MX2017014538A (es) | Regimenes de cebado-refuerzo que implican la administracion de al menos un constructo de arnm. | |
JP2016525102A5 (ja) | ||
RU2020117033A (ru) | Комплекс, содержащий олигонуклеотид, обладающий иммуностимулирующей активностью, и его применение | |
NO20074638L (no) | Ny sammensetning | |
MX2013004817A (es) | Enfermedad inflamatoria. | |
WO2009095226A3 (en) | NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS | |
RU2012100719A (ru) | Синергетическая смесь бета-галактоолигосахаридов с бета-1,3 и бета-1,4/1,6 связями | |
JP2013534248A5 (ja) | ||
JP2011250797A5 (ja) | ||
MX2013012289A (es) | Triazolopiridinas. | |
JP2013520167A5 (ja) | ||
PH12015501637A1 (en) | Inactivated dengue virus vaccine with aluminium-free adjuvant | |
JP2014001235A5 (ja) | ||
JP2014520136A5 (ja) | ||
JP2017524682A5 (ja) | ||
NZ597000A (en) | Compositions and methods for administration of vaccines against dengue virus | |
JP2011525902A5 (ja) | ||
MX2015007753A (es) | Composicion de vacunas para sujetos intactos. | |
JP2016106117A5 (ja) | ||
JP2012527218A5 (ja) | ||
Kim et al. | Intranasal administration of poly-gamma glutamate induced antiviral activity and protective immune responses against H1N1 influenza A virus infection | |
JP2012504948A5 (ja) |